Results 21 to 30 of about 5,761 (235)

Effect of Diethylstilbestrol and Norethindrone on Sex Ratio and Body Indices of Common Carp, Cyprinus carpio (Linn.)

Asian Fisheries Science, 2010
B. H. VINOD
doaj   +2 more sources

Norethindrone-Associated Transaminitis in Endometriosis Patients: A Case Series and Literature Review. [PDF]

Cureus
Rosario SA, Mikhail E, Encalada Soto D.
europepmc   +3 more sources

Norethindrone

, 2006
James L. Schardein, Orest T. Macina
europepmc   +3 more sources

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials [PDF]

F&S Reports
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D., Elizabeth A. Stewart, M.D., Susan Jewell, Ph.D., Moming Li, Ph.D., Michael C. Snabes, M.D., Ph.D.   +4 more
doaj   +2 more sources

Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084. [PDF]

J Int AIDS Soc
Abstract Introduction HPTN 084 found that long‐acting cabotegravir (CAB‐LA) was well‐tolerated and significantly reduced the risk of HIV acquisition in women compared to tenofovir disoproxil fumarate/emtricitabine (F/TDF). During the blinded phase of the trial, participants were required to use an effective method of contraception, including an ...
Marzinke MA, Hanscom B, Haines D, Scarsi KK, Agyei Y, Piwowar-Manning E, Hendrix CW, Gollings R, Rose S, Mathew C, Panchia R, Spooner E, Singh N, Bock P, Rinehart AR, Ford SL, Rooney JF, Soto-Torres L, Cohen MS, Hosseinipour MC, Delany-Moretlwe S, HPTN 084 Study Team.   +21 more
europepmc   +2 more sources

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. [PDF]

, 2020
Progestins are widely used for the treatment of gynecologic disorders and alone, or combined with an estrogen, are used as contraceptives. While their potencies, efficacies and side effects vary due to differences in structures, doses and routes of ...
Balayan, Shayna, Chen, Joseph C, Giudice, Linda C, Greenblatt, Ruth M, Houshdaran, Sahar, Irwin, Juan C, Smith-McCune, Karen, Vallvé-Juanico, Júlia, Vo, Kim Chi   +8 more
core   +2 more sources

Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis

BMC Women's Health, 2022
Background Elagolix is effective and safe for treating menorrhagia in women with uterine fibroid. However, it is reported to be associated with hypoestrogenism that can be alleviated by adding estradiol/norethindrone acetate.
Juliawati Muhammad, Yusnita Yusof, Imran Ahmad, Mohd Noor Norhayati   +3 more
doaj   +1 more source

DDDR-32. EXPLORING ANDROGENIC MODULATION IN GLIOBLASTOMA: POTENCY AND SELECTIVITY OF NOVEL NORETHINDRONE DERIVATIVES [PDF]

Neuro Oncol
Richard W. Dudley, Ryan A. Schneider, C.B. Shoemaker, Lea Stitzlein   +3 more
europepmc   +3 more sources

Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma

Drug Delivery, 2022
Malignant ascites is a common complication of some advanced cancers. Although intraperitoneal (IP) administration of chemotherapy drugs is routinely used to treat cancerous ascites, conventional drugs have poor retention and therefore need to be ...
Susu Xiao, Yu Wang, Wenqiong Ma, Ping Zhou, Biqiong Wang, Zhouxue Wu, Qian Wen, Kang Xiong, Yanlin Liu, Shaozhi Fu   +9 more
doaj   +1 more source

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases

Gynecologic Oncology Reports, 2017
Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months or even years.
William L. Read, Sumita Trivedi, Felicia Williams   +2 more
doaj   +1 more source